Aurinia Pharmaceuticals Inc. Earnings Per Share, Basic in USD/shares from 2019 to Q3 2025

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Summary
Aurinia Pharmaceuticals Inc. quarterly/annual Earnings Per Share, Basic history and growth rate from 2019 to Q3 2025.
  • Aurinia Pharmaceuticals Inc. Earnings Per Share, Basic for the quarter ending September 30, 2025 was 0.24 USD/shares, a 140% increase year-over-year.
  • Aurinia Pharmaceuticals Inc. Earnings Per Share, Basic for the twelve months ending September 30, 2025 was 0 USD/shares.
  • Aurinia Pharmaceuticals Inc. annual Earnings Per Share, Basic for 2024 was 0.04 USD/shares.
  • Aurinia Pharmaceuticals Inc. annual Earnings Per Share, Basic for 2023 was -0.54 USD/shares, a 28.9% increase from 2022.
  • Aurinia Pharmaceuticals Inc. annual Earnings Per Share, Basic for 2022 was -0.76 USD/shares, a 45.7% increase from 2021.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Quarterly (USD/shares)
Earnings Per Share, Basic, YoY Quarterly Growth (%)
Earnings Per Share, Basic, Annual (USD/shares)
Earnings Per Share, Basic, YoY Annual Growth (%)

Aurinia Pharmaceuticals Inc. Quarterly Earnings Per Share, Basic (USD/shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $0 $0.24 +$0.14 +140% Jul 1, 2025 Sep 30, 2025 10-Q 2025-11-04
Q2 2025 $0 $0.16 +$0.15 +1500% Apr 1, 2025 Jun 30, 2025 10-Q 2025-07-31
Q1 2025 $0 $0.17 +$0.24 Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-12
Q4 2024 $0 $0.01 +$0.20 Oct 1, 2024 Dec 31, 2024 10-K 2025-02-27
Q3 2024 $0 $0.10 +$0.19 Jul 1, 2024 Sep 30, 2024 10-Q 2025-11-04
Q2 2024 $0 $0.01 +$0.09 Apr 1, 2024 Jun 30, 2024 10-Q 2025-07-31
Q1 2024 $0 $0 +$0.11 +61.1% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-12
Q4 2023 $0 $0 $0 -5.56% Oct 1, 2023 Dec 31, 2023 10-K 2025-02-27
Q3 2023 $0 $0 $0 -50% Jul 1, 2023 Sep 30, 2023 10-K 2025-02-27
Q2 2023 $0 $0 +$0.17 +68% Apr 1, 2023 Jun 30, 2023 10-K 2025-02-27
Q1 2023 $0 $0 +$0.09 +33.3% Jan 1, 2023 Mar 31, 2023 10-K 2025-02-27
Q4 2022 $0 $0 +$0.07 +28% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-15
Q3 2022 $0 $0 +$0.33 +84.6% Jul 1, 2022 Sep 30, 2022 10-K 2024-02-15
Q2 2022 -$1 $0 +$0.12 +32.4% Apr 1, 2022 Jun 30, 2022 10-K 2024-02-15
Q1 2022 -$1 $0 +$0.13 +32.5% Jan 1, 2022 Mar 31, 2022 10-K 2024-02-15
Q4 2021 -$1 $0 $0 -317% Oct 1, 2021 Dec 31, 2021 10-K 2023-02-28
Q3 2021 -$1 $0 $0 -14.7% Jul 1, 2021 Sep 30, 2021 10-K 2023-02-28
Q2 2021 -$1 $0 $0 -54.2% Apr 1, 2021 Jun 30, 2021 10-K 2023-02-28
Q1 2021 -$1 $0 $0 -73.9% Jan 1, 2021 Mar 31, 2021 10-K 2023-02-28
Q4 2020 $0 $0 Oct 1, 2020 Dec 31, 2020 10-K 2022-02-28
Q3 2020 $0 Jul 1, 2020 Sep 30, 2020 10-K 2022-02-28
Q2 2020 $0 Apr 1, 2020 Jun 30, 2020 10-K 2022-02-28
Q1 2020 $0 Jan 1, 2020 Mar 31, 2020 10-K 2022-02-28

Aurinia Pharmaceuticals Inc. Annual Earnings Per Share, Basic (USD/shares)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $0.04 +$0.58 Jan 1, 2024 Dec 31, 2024 10-K 2025-02-27
2023 -$1 +$0.22 +28.9% Jan 1, 2023 Dec 31, 2023 10-K 2025-02-27
2022 -$1 +$0.64 +45.7% Jan 1, 2022 Dec 31, 2022 10-K 2025-02-27
2021 -$1 -$1 -60.9% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-15
2020 -$1 +$0.08 +8.42% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-28
2019 -$1 Jan 1, 2019 Dec 31, 2019 10-K 2022-02-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.